Corbus Pharmaceuticals Holdings, Inc. (CRBP) SEC Filings https://ir.corbuspharma.com/sec-filings/all-sec-filings/rss Corbus Pharmaceuticals Holdings, Inc. (CRBP) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/_dc5231ac157b9ee4fb322b64fcb7a082/corbuspharma/files/theme/images/logo-sm.png Corbus Pharmaceuticals Holdings, Inc. Logo Equisolve Investor Relations Suite <![CDATA[8-K - Current report]]> https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-222890/0001193125-26-222890.pdf Thu, 14 May 26 00:00:00 -0400 https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-222890/0001193125-26-222890.pdf <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-219707/0001193125-26-219707.pdf Tue, 12 May 26 00:00:00 -0400 https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-219707/0001193125-26-219707.pdf <![CDATA[8-K - Current report]]> https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-218250/0001193125-26-218250.pdf Tue, 12 May 26 00:00:00 -0400 https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-218250/0001193125-26-218250.pdf <![CDATA[DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material]]> https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-159074/0001193125-26-159074.pdf Thu, 16 Apr 26 00:00:00 -0400 https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-159074/0001193125-26-159074.pdf <![CDATA[8-K - Current report]]> https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-159062/0001193125-26-159062.pdf Thu, 16 Apr 26 00:00:00 -0400 https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-159062/0001193125-26-159062.pdf <![CDATA[8-K - Current report]]> https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-153923/0001193125-26-153923.pdf Tue, 14 Apr 26 00:00:00 -0400 https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-153923/0001193125-26-153923.pdf <![CDATA[8-K - Current report]]> https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-144588/0001193125-26-144588.pdf Tue, 07 Apr 26 00:00:00 -0400 https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-144588/0001193125-26-144588.pdf <![CDATA[ARS - Annual Report to Security Holders]]> https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-140398/0001193125-26-140398.pdf Thu, 02 Apr 26 00:00:00 -0400 https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-140398/0001193125-26-140398.pdf <![CDATA[DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material]]> https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-140385/0001193125-26-140385.pdf Thu, 02 Apr 26 00:00:00 -0400 https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-140385/0001193125-26-140385.pdf <![CDATA[DEF 14A - Definitive proxy statements]]> https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-140363/0001193125-26-140363.pdf Thu, 02 Apr 26 00:00:00 -0400 https://ir.corbuspharma.comhttps://ir.corbuspharma.com/sec-filings/all-sec-filings/content/0001193125-26-140363/0001193125-26-140363.pdf